These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 33603357)
1. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study. Leung C; Bourbeau J; Sin DD; Aaron SD; FitzGerald JM; Maltais F; Marciniuk DD; O'Donnell D; Hernandez P; Chapman KR; Walker B; Road JD; Zheng L; Zou C; Hogg JC; Tan WC; Int J Chron Obstruct Pulmon Dis; 2021; 16():305-320. PubMed ID: 33603357 [TBL] [Abstract][Full Text] [Related]
2. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS). Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908 [TBL] [Abstract][Full Text] [Related]
3. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies. Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947 [TBL] [Abstract][Full Text] [Related]
4. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study. Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413 [TBL] [Abstract][Full Text] [Related]
5. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: Findings from a Community-based Household Survey. Adhikari TB; Acharya P; Högman M; Neupane D; Karki A; Drews A; Cooper BG; Sigsgaard T; Kallestrup P Int J Chron Obstruct Pulmon Dis; 2020; 15():2319-2331. PubMed ID: 33061350 [TBL] [Abstract][Full Text] [Related]
7. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140 [TBL] [Abstract][Full Text] [Related]
8. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group. Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey. Pefura-Yone EW; Kengne AP; Balkissou AD; Magne-Fotso CG; Ngo-Yonga M; Boulleys-Nana JR; Efe-de-Melingui NR; Ndjeutcheu-Moualeu PI; Mbele-Onana CL; Kenmegne-Noumsi EC; Kolontchang-Yomi BL; Theubo-Kamgang BJ; Ebouki ER; Djuikam-Kamga CK; Amougou F; Mboumtou L; Petchou-Talla EL; Kuaban C; BMC Res Notes; 2016 Feb; 9():124. PubMed ID: 26917543 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study. Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study. Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136 [TBL] [Abstract][Full Text] [Related]
12. Self-reported physician-diagnosed chronic obstructive pulmonary disease and spirometry patterns in Vietnam Era US Army Chemical Corps veterans: A retrospective cohort study. Cypel YS; Hines SE; Davey VJ; Eber SM; Schneiderman AI Am J Ind Med; 2018 Oct; 61(10):802-814. PubMed ID: 30159906 [TBL] [Abstract][Full Text] [Related]
13. COPD in chronic heart failure: less common than previously thought? Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial. Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827 [TBL] [Abstract][Full Text] [Related]
15. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease. Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP; Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927 [No Abstract] [Full Text] [Related]
16. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J; Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248 [TBL] [Abstract][Full Text] [Related]
17. Fixed ratio or lower limit of normal for the FEV Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study. Runarsdottir SB; Gudmundsson G; Aspelund T; Harris TB; Launer LJ; Gudnason V; Gislason T COPD; 2013 Aug; 10(4):493-9. PubMed ID: 23875743 [TBL] [Abstract][Full Text] [Related]
19. Association between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study. Zhang DD; Liu JN; Ye Q; Chen Z; Wu L; Peng XQ; Lu G; Zhou JY; Tao R; Ding Z; Xu F; Zhou L Chin Med J (Engl); 2021 Jun; 134(13):1552-1560. PubMed ID: 34250960 [TBL] [Abstract][Full Text] [Related]
20. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. Tan WC; Bourbeau J; FitzGerald JM; Cowie R; Chapman K; Hernandez P; Buist SA; Sin DD Int J Tuberc Lung Dis; 2011 Dec; 15(12):1691-8. PubMed ID: 22118181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]